MH

Mahesh Hakmichand Doshi

Active Director Director DIN 00502819
DIN 00502819 First appointment Feb 1991 Primary industry Manufacturing
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Feb 1991
Shareholding value •••• Premium profile

About Mahesh Hakmichand Doshi

Data last updated:

Mahesh Hakmichand Doshi is a Director at Avesta Pharma Private Limited (since 2015) and Director at Accusynth Speciality Chemicals Private Limited (since 2006). The companies operate in Manufacturing, Chemicals and Materials and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹227 Cr; the largest is Avesta Pharma Private Limited at ₹202 Cr (FY 2025). Earlier, Mahesh Hakmichand Doshi was a Director at Nutraplus India Limited (1996–2014) and Director at Dyna Glycols Private Limited (2015–2018) and 1 more.

DIN 00502819
Primary Designation Director
Industry Manufacturing
First Appointment 13 Feb 1991
Oldest Company Age 47 yrs
Largest company Avesta Pharma Private Limited · ₹202 Cr (FY 2025)
Combined revenue ₹227 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avesta Pharma Private Limited U24239MH2009PTC192677
Director01 Apr 20152009₹202 Cr (FY 2025)Active
Director27 Jul 20061979₹24.90 Cr (FY 2020)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nutraplus India Limited L24230MH1990PLC055347
Director30 Apr 19961990Active
Dyna Glycols Private Limited U24119MH2006PTC164262
Director01 Apr 20152006₹303 Cr (FY 2024)Active
Arihant Organics P Ltd U24100MH1991PTC060278
Director13 Feb 19911991₹16.6 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Accusynth Speciality Chemicals Private Limited
Avesta Pharma Private Limited
Nutraplus India Limited
Dyna Glycols Private Limited
Premium access

Shareholding and investment profile for Mahesh Hakmichand Doshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Hakmichand Doshi

Mahesh Hakmichand Doshi currently holds 2 directorships: Avesta Pharma Private Limited (Director, since 01 Apr 2015, revenue ₹202 Cr (FY 2025)); Accusynth Speciality Chemicals Private Limited (Director, since 27 Jul 2006, revenue ₹24.90 Cr (FY 2020)).

Mahesh Hakmichand Doshi was first appointed on 13 Feb 1991 as Director at Arihant Organics P Ltd. The most recent appointment on record is 01 Apr 2015 at Dyna Glycols Private Limited.

The 2 current companies of Mahesh Hakmichand Doshi that report revenue have a combined latest revenue of ₹227 Cr: Avesta Pharma Private Limited ₹202 Cr (FY 2025); Accusynth Speciality Chemicals Private Limited ₹24.90 Cr (FY 2020).

Mahesh Hakmichand Doshi held 3 earlier board appointments: Nutraplus India Limited (Director, 30 Apr 1996 to 14 Nov 2014); Dyna Glycols Private Limited (Director, 01 Apr 2015 to 02 Jun 2018); Arihant Organics P Ltd (Director, 13 Feb 1991 to 17 Aug 2009).

The current boards of Mahesh Hakmichand Doshi's companies include Amol Ashok Walke (Avesta Pharma Private Limited), Eric Kersi Tangri (Avesta Pharma Private Limited), Kersi Homi Tangri (Avesta Pharma Private Limited), Zubin Keki Gandhi (Avesta Pharma Private Limited), Karl Kersi Tangri (Accusynth Speciality Chemicals Private Limited), Niraj Mahesh Doshi (Accusynth Speciality Chemicals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available